Clinical studies recruiting near Wels

Studies with at least one listed site matching this location on the public registry. Each page explains the study in plain language, with locations and study-team contacts. Clinicians: generate a printable list for your patient →

Austrian PBC Registry
Phase N/A · Klinikum Wels-Grieskirchen · Medical University of Vienna · NCT07598669 Sacituzumab Tirumotecan (MK-2870) Plus Pembrolizumab Versus TPC in TNBC Who Did Not Achieve pCR (MK-2870-012)
Phase 3 · Klinikum Wels-Grieskirchen ( Site 1205) · Merck Sharp & Dohme LLC · NCT06393374 Methods of T Cell Depletion Trial (MoTD)
Phase 2 · University of Birmingham · NCT04888741 A Study of Bempedoic Acid in Combination With Ezetimibe and Either Rosuvastatin or Atorvastatin in Patients With Primary
Phase N/A · Daiichi Sankyo Europe, GmbH, a Daiichi Sankyo Company · NCT06686615 A Study of the Safety and Activity of Sparsentan for the Treatment of Patients With Immunoglobulin A Nephropathy
Phase 2 · University of Leicester · NCT04663204 A Study to Assess the Efficacy and Safety of Efgartigimod IV in Adult Participants With Primary Immune Thrombocytopenia
Phase 3 · Klinikum Kreuzschwestern Wels · argenx · NCT06544499 A Study of Guselkumab Versus Risankizumab in Participants With Moderately to Severely Active Crohn's Disease
Phase 3 · Klinikum Wels Grieskirchen · Janssen Research & Development, LLC · NCT07499232 A Study to Evaluate Patient-Reported Satisfaction, Effectiveness, and Safety of Atezolizumab in Participants Treated in
Phase N/A · Klinikum Wels-Grieskirchen · Hoffmann-La Roche · NCT07284121 A Study to Compare How Well Odronextamab Combined With Chemotherapy Works and How Safe it is Against Rituximab Combined
Phase 3 · Klinikum Wels-Grieskirchen · Regeneron Pharmaceuticals · NCT06091865 Seladelpar in Subjects With Primary Biliary Cholangitis (PBC) and Compensated Cirrhosis
Phase 3 · Klinikum Wels-Grieskirchen GmbH - Standort Wels · Gilead Sciences · NCT06051617 PHOENIX DDR/Anti-PD-L1 Trial: A Pre-surgical Window of Opportunity and Post-surgical Adjuvant Biomarker Study of DNA Dam
Phase 2 · Institute of Cancer Research, United Kingdom · NCT03740893 Investigating the Metabolic and Lipidomic Profiles That Are Associated With Varying Grades of Diabetic Maculopathy and R
Phase N/A · Hywel Dda Health Board · NCT06914778 A Study to Assess Disease Activity and Adverse Events of Intravenous (IV) Telisotuzumab Vedotin Compared to IV Docetaxel
Phase 3 · Klinikum Wels-Grieskirchen Gmbh /ID# 249000 · AbbVie · NCT04928846 Pan Tumor Rollover Study
Phase 2 · Local Institution - 0145 · Bristol-Myers Squibb · NCT03899155 Phase III, Open-label, Study of First-line Dato-DXd in Combination With Rilvegostomig for Advanced Non-squamous NSCLC Wi
Phase 3 · Research Site · AstraZeneca · NCT06357533 A Study to Compare the Efficacy of Nivolumab and Relatlimab Plus Chemotherapy vs Pembrolizumab Plus Chemotherapy for Sta
Phase 3 · Klinikum Wels-Grieskirchen GmbH · Bristol-Myers Squibb · NCT06561386 An Adjuvant Endocrine-based Therapy Study of Camizestrant (AZD9833) in ER+/HER2- Early Breast Cancer (CAMBRIA-2)
Phase 3 · Research Site · AstraZeneca · NCT05952557 Diagnostic HER2DX-guided Treatment for Patients wIth Early-stage HER2-positive Breast Cancer
NA · Klinikum Wels-Grieskirchner · Fundacio Clinic Barcelona · NCT06446882 An Open Label Extension (OLE) Study (Following Completion of CTQJ230A12301) to Evaluate Long-term Safety and Tolerabilit
Phase 3 · Novartis Pharmaceuticals · NCT07517263 OP-1250 (Palazestrant) vs. Standard of Care for the Treatment of ER+/HER2- Advanced Breast Cancer
Phase 3 · Clinical Trial Site · Olema Pharmaceuticals, Inc. · NCT06016738 Iberdomide vs. Iberdomide Plus Isatuximab Maintenance Therapy Post ASCT in Newly Diagnosed Multiple Myeloma
Phase 3 · Klinikum Wels-Grieskirchen GmbH · University of Heidelberg Medical Center · NCT06216158 Isometric Handgrip Training Frequency and Blood Pressure in People With Hypertension
NA · Swansea University · NCT06335433 Fast Discharge After Acute Myocardial Infarction Discharge MI
NA · University Teaching Hospital Wels-Grieskirchen · Medical University Innsbruck · NCT06744322 LIVERAGE™ - Cirrhosis: A Study to Test Whether Survodutide Helps People With a Liver Disease Called NASH/MASH Who Have C
Phase 3 · Klinikum Wels - Grieskirchen GmbH · Boehringer Ingelheim · NCT06632457 Study on Efficacy and Safety of Givinostat Versus Hydroxyurea in Patients With Polycythemia Vera
Phase 3 · Klinikum Wels-Grieskirchen GmbH · Italfarmaco · NCT06093672 The Early Valve Replacement in Severe ASYmptomatic Aortic Stenosis Study
NA · University of Leicester · NCT04204915 Study of Opevesostat (MK-5684) Versus Alternative NHA in mCRPC (MK-5684-003)
Phase 3 · Klinikum Wels-Grieskirchen GmbH ( Site 0279) · Merck Sharp & Dohme LLC · NCT06136624 A Study of Trastuzumab DeRuxtecan for Patients With Advanced HER2-pOsitive GaStric or GastroesoPhageal Junction AdEnocar
Phase N/A · Kepler Universitätsklinikum · Daiichi Sankyo Europe, GmbH, a Daiichi Sankyo Company · NCT05993234 A Study of ATTR-01 in Participants With Select Epithelial Solid Tumours
Phase 1/Phase 2 · Accession Therapeutics Limited · NCT06977737 (HARBOR) Study to Evaluate Efficacy and Safety of BLU-263 Versus Placebo in Patients With Indolent Systemic Mastocytosis
Phase 2/Phase 3 · Blueprint Medicines Corporation · NCT04910685

Look up another city

Look up another condition